Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Volumn 1, Issue , 2014, Pages 1194-1215

  Pasternack, Mark S ^a   Swartz, Morton N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Carbuncles; Cellulitis; Diabetic ulcers; Ecthyma; Erysipelas; Folliculitis; Furuncles; Gangrene; Impetigo; Necrotizing fasciitis; Pyoderma

Indexed keywords

EID: 84944531099     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-4801-3.00095-3     Document Type: Chapter

References (284)

1. Rørtveit S, Rørtveit G Impetigo in epidemic and nonepidemic phases: an incidence study over years in a general population. Br J Dermatol 2007, 157:100-105.
2. Rørtveit S, Skutlaberg DH, Langeland N, et al. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics. J Antimicrob Chemother 2011, 66:1360-1364.
3. Ferrieri P, Dajani AS, Wannamaker LW, et al. Natural history of impetigo, I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest 1972, 51:2851-2862.
4. Bisno AL, Stevens DL Streptococcal infections of skin and soft tissues. N Engl J Med 1996, 334:240-245.
5. Durupt F, Mayor L, Bes M, et al. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br J Dermatol 2007, 157:1161-1167.
6. Dajani AS, Ferrieri P, Wannamaker LW Natural history of impetigo, II. Etiologic agents and bacterial interactions. J Clin Invest 1972, 51:2863-2871.
7. Hochedez P, Canestri A, Lecso M, et al. Skin and soft tissue infections in returning travelers. Am J Trop Med Hyg 2009, 80:431-434.
8. Darmstadt GL, Fleckman P, Jonas M, et al. Differentiation of cultured keratinocytes promotes the adherence of Streptococcus pyogenes. J Clin Invest 1998, 101:128-136.
9. Okada N, Pentland AP, Falk P, et al. M protein and protein F act as important determinations of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest 1994, 94:965-977.
10. Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5:275-286.
11. Dillon HC Post-streptococcal glomerulonephritis following pyoderma. Rev Infect Dis 1979, 1:935-945.
12. Bessen DE, McGregor KF, Whatmore AM Relationships between emm and multilocus sequence types within a global collection of Streptococcus pyogenes. BMC Microbiol 2008, 8:59-70.
13. Burge SM, Ryan TJ Acute palmoplantar pustulosis. Br J Dermatol 1985, 113:77-83.
14. McLaughlin J, Low JC Primary cutaneous listeriosis in adults: an occupational disease of veterinarians and farmers. Vet Rec 1994, 135:615-617.
15. Brown J, Shriner DL, Schwartz RA, et al. Impetigo: an update. Int J Dermatol 2003, 42:251-255.
16. Bowen AC, Lilliebridge RA, Tong SY, et al. Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?. J Clin Microbiol 2012, 50:4067-4072.
17. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41:1373-1406. Infectious Diseases Society of America.
18. Bangert S, Levy M, Hebert AA Bacterial resistance and impetigo treatment trends: a review. Pediatr Dermatol 2012, 29:243-248.
19. Koning S, van der Wouden JC, Chosidow O, et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol 2008, 158:1077-1082.
20. Bukowski M, Wladyka B, Dubin G Exfoliative toxins of Staphylococcus aureus. Toxins 2010, 2:1148-1165.
21. Stanley JR, Amagai M Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006, 355:1800-1810.
22. Hubiche T, Bes M, Roudiere L, et al. Mild staphylococcal scalded skin syndrome: an underdiagnosed clinical disorder. Br J Dermatol 2012, 166:213-215.
23. Knox BL, Petska HW, DeMuri GP, et al. Staphylococcal infection mimicking child abuse: what is the differential diagnosis and appropriate evaluation?. Pediatr Emerg Care 2011, 27:547-549.
24. Murray RJ Recognition and management of Staphylococcus aureus toxin-mediated disease. Intern Med J 2005, 35(suppl 2):S106-S119.
25. Curran JP, Al-Salihi FL Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type. Pediatrics 1980, 66:285-290.
26. Lina G, Gillet Y, Vandenesch F, et al. Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis 1997, 25:1369-1373.
27. Lappin E, Ferguson AJ Gram-positive toxic shock syndromes. Lancet Infect Dis 2009, 9:281-290.
28. Levy AL, Simpson G, Skinner RB Medical pearl: circle of desquamation-a clue to the diagnosis of folliculitis and furunculosis caused by Staphylococcus aureus. J Am Acad Dermatol 2006, 55:1079-1080.
29. Yu Y, Cheng AS, Wang L, et al. Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa. J Am Acad Dermatol 2007, 57:596-600.
30. El Baze P, Thyss A, Caldini C, et al. Pseudomonas aeruginosa 0-11 folliculitis: development into ecthyma gangrenosum in immunosuppressed patients. Arch Dermatol 1985, 121:873-876.
31. Stähelin-Massik J, Gnehm HE, Itin PH Pseudomonas folliculitis in a young child. Pediatr Infect Dis J 2000, 19:362-363.
32. Neubert U, Jansen H, Plewig G Bacteriologic and immunologic aspects of gram-negative folliculitis: a study of 46 patients. Int J Dermatol 1999, 38:270-274.
33. Archer-Dubon C, Icaza-Chivez ME, Orozco-Topete R An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecognized nosocomial infection. Int J Dermatol 1999, 38:453-456.
34. Tragiannidis A, Bisping G, Koehler G, et al. Minireview: Malassezia infections in immunocompromised patients. Mycoses 2010, 53:187-195.
35. Ayers K, Sweeney SM, Wiss K Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med 2005, 159:64-67.
36. Campanelli A, Marazza G, Stucki L, et al. Fulminant herpetic sycosis: atypical presentation of primary herpetic infection. Dermatology 2004, 208:284-286.
37. Talbot TR, Bredenberg HK, Smith M, et al. Focal and generalized folliculitis following smallpox vaccination among vaccinia-naive recipients. JAMA 2003, 289:3290-3294.
38. Sanfilippo AM, English JC Resistant scalp folliculitis secondary to Demodex infestation. Cutis 2005, 76:321-324.
39. Nervi SJ, Schwartz RA, Dmochowski M Eosinophilic pustular folliculitis: a 40-year retrospect. J Am Acad Dermatol 2006, 55:285-289.
40. Okuyama R, Masu T, Kumasaka N, et al. Amicrobial pustulosis of the folds affecting a young male without any accompanying autoimmune diseases. Dermatology 2008, 217:121-123.
41. Lee HY, Pelivani N, Beltraminelli H, et al. Amicrobial pustulosis-like rash in a patient with Crohn's disease under anti-TNF-alpha blocker. Dermatology 2011, 222:304-310.
42. Sladden MJ, Johnston GA More common skin infections in children. BMJ 2005, 330:1194-1198.
43. Moellering RC, Abbott GF, Ferraro MJ Case records of the Massachusetts General Hospital. Case 2-2011. A 30-year-old woman with shock after treatment of a furuncle. N Engl J Med 2011, 364:266-275.
44. Baba-Moussa L, Sina H, Scheftel JM, et al. Staphylococcal Panton-Valentine leucocidin as a major virulence factor associated to furuncles. PLoS One 2011, 6:e25716.
45. Johnston SL Clinical immunology review series: an approach to the patient with recurrent superficial abscesses. Clin Exp Immunol 2008, 152:397-405.
46. Demos M, McLeod MP, Nouri K Recurrent furunculosis: a review of the literature. Br J Dermatol 2012, 167:725-732.
47. Huang JT, Abrams M, Tlougan B, et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009, 123:e808-e814.
48. Ammerlaan HS, Kluytmans JA, Wertheim HF, et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009, 48:922-930.
49. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44:178-185.
50. Fritz SA, Hogan PG, Camins BC, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013, 57:559-568.
51. Sniezek PJ, Graham BS, Busch HB, et al. Rapidly growing mycobacterial infections after pedicures. Arch Dermatol 2003, 139:629-634.
52. Wasserzug O, Valinsky L, Klement E, et al. A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes. Clin Infect Dis 2009, 48:1213-1219.
53. Hewitt WD, Farrar WE Case report: bacteremia and ecthyma caused by Streptococcus pyogenes in a patient with acquired immunodeficiency syndrome. Am J Med Sci 1988, 295:52-54.
54. Centers for Disease Control and Prevention (CDC) Gastrointestinal anthrax after an animal-hide drumming event-New Hampshire and Massachusetts, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:872-877.
55. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon 2002: updated recommendations for management. JAMA 2002, 287:2236-2252.
56. Smego RA, Gebrain B, Desmangels G Cutaneous manifestations of anthrax in rural Haiti. Clin Infect Dis 1998, 26:97-101.
57. Swartz MN Recognition and treatment of anthrax: an update. N Engl J Med 2001, 345:1621-1626.
58. Centers for Disease Control and Prevention (CDC) Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001, 50:909-919.
59. Bernard P, Bedame C, Mounier M, et al. Streptococcal cause of erysipelas and cellulitis in adults. Arch Dermatol 1989, 125:779-782.
60. Gunderson CG, Martinello RA A systematic review of bacteremias in cellulitis and erysipelas. J Infect 2012, 64:148-155.
61. Jorup-Ronstrom C Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986, 18:519-524.
62. Damstra RJ, van Steensel MA, Boomsma JH, et al. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol 2008, 158:1210-1215.
63. Eriksson BKG Anal colonization of group G β-hemolytic streptococci in relapsing erysipelas of the lower extremity. Clin Infect Dis 1999, 29:1319-1320.
64. Del Giudice P, van der Mee-Marquet N, David-Rubin F, et al. Severe relapsing erysipelas associated with chronic Streptococcus agalactiae vaginal colonization. Clin Infect Dis 2006, 43:e67-e70.
65. Guberman D, Gilead LT, Zlotogorski A, et al. Bullous erysipelas: a retrospective study of 26 patients. J Am Acad Dermatol 1999, 41:733-737.
66. Krasagakis K, Samonis G, Maniatakis P, et al. Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. Dermatology 2006, 212:31-35.
67. Kerstens PJ, Endtz HP, Meis JF, et al. Erysipelas-like lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur J Clin Microbiol Infect Dis 1992, 11:842-847.
68. Leclerc S, Teixeira A, Mahé E, et al. Recurrent erysipelas: 47 cases. Dermatology 2007, 214:52-57.
69. Baddour LM, Bisno AL Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann Intern Med 1982, 97:493-496.
70. Crouch JD, O'Hair DP, Keuler JP, et al. Open versus endoscopic saphenous vein harvesting: wound complications and vein quality. Ann Thorac Surg 1999, 68:1513-1516.
71. Chmel H, Hamdy M Recurrent streptococcal cellulitis complicating radical hysterectomy and radiation therapy. Obstet Gynecol 1984, 63:862-864.
72. Simon MS, Cody RL Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med 1992, 93:543-548.
73. Mertz KR, Baddour LM, Bell JL, et al. Breast cellulitis following breast conservation therapy: a novel complication of medical progress. Clin Infect Dis 1998, 26:481-486.
74. Ellison RT, McGregor JA Recurrent postcoital lower extremity streptococcal erythroderma in women: streptococcal-sex syndrome. JAMA 1987, 257:3260-3262.
75. Barzilae A, Choen HA Isolation of group A streptococci from children with perianal cellulitis and from their siblings. Pediatr Infect Dis J 1998, 17:358-360.
76. Swartz MN Cellulitis. N Engl J Med 2004, 350:904-912.
77. Givner LB, Mason EO, Barson WJ, et al. Pneumococcal facial cellulitis in children. Pediatrics 2000, 106:E61.
78. Capdevila O, Grau I, Vadillo M, et al. Bacteremic pneumococcal cellulitis compared with bacteremic cellulitis caused by Staphylococcus aureus and Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis 2003, 22:337-341.
79. Durvanel T, Auckenthaler R, Rohner P, et al. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med 1989, 149:293-296.
80. Hook EW, Hooton TM, Horton CA, et al. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986, 146:295-297.
81. Howe PM, Fajardo JE, Orcutt MA Etiologic diagnosis of cellulitis: comparison of aspirates obtained from the leading edge and the point of maximal inflammation. Pediatr Infect Dis J 1987, 6:685-686.
82. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012, 54:e132-e173.
83. Kitamura T, Kawamura Y, Ohkusu K, et al. Helicobacter cinaedi cellulitis and bacteremia in immunocompetent hosts after orthopedic surgery. J Clin Microbiol 2007, 45:31-38.
84. Peralta G, Padrón E, Roiz MP, et al. Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis 2006, 25:619-626.
85. Woo PC, Lum PML, Wong SSY, et al. Cellulitis complicating lymphoedema. Eur J Clin Microbiol Infect Dis 2000, 19:294-297.
86. Brooke CJ, Riley TV Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol 1999, 48:789-799.
87. Lewin MR, Knott P, Lo M Seal finger. Lancet 2004, 364:448.
88. Gold WL, Salit IE Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis 1993, 16:69-74.
89. Dechet AM, Yu PA, Koram N, et al. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006. Clin Infect Dis 2008, 46:970-976.
90. Chuang Y-C, Yuan C-Y, Liu C-Y, et al. Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 1992, 15:271-276.
91. Kielbauch JA, Tauxe RV, Baker CN, et al. Helicobacter cinaedi-associated bacteremia and cellulitis in immunocompromised patients. Ann Intern Med 1994, 121:90-93.
92. Horrevorts AM, Huysmans FTM, Koopman RJJ, et al. Cellulitis as first clinical presentation of disseminated cryptococcosis in renal transplant recipients. Scand J Infect Dis 1994, 26:623-626.
93. Nucci M, Anaissie E Fusarium infections in immuno-compromised patients. Clin Microbiol Rev 2007, 20:695-704.
94. Waldor MK, Wilson B, Swartz M Cellulitis caused by Legionella pneumophila. Clin Infect Dis 1993, 16:51-53.
95. Kilborn JA, Manz LA, O'Brien M, et al. Necrotizing cellulitis caused by Legionella micdadei. Am J Med 1992, 92:104-106.
96. Sleiman JN, D'Angelo A, Hammerschlag MR Spontaneous Escherichia coli cellulitis in a child with nephrotic syndrome. Pediatr Infect Dis J 2007, 26:266-267.
97. Sunder S, Haguenoer E, Bouvet D, et al. Life-threatening Escherichia coli cellulitis in patients with haematological malignancies. J Med Microbiol 2012, 61:1324-1327.
98. Falagas ME, Vergidis PI Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005, 142:47-55.
99. Prentice O, Fernandez WG, Luyber TJ, et al. Stonefish envenomation. Am J Emerg Med 2008, 26:972.e1-972.e2.
100. Majeed HA, Quabazard Z, Hijasi Z, et al. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis): a six-year study. QJM 1990, 75:607-616.
101. Abbas O, Kibbi AG, Rubeiz N Sweet's syndrome: retrospective study of clinical and histologic features of 44 cases from a tertiary care center. Int J Dermatol 2010, 49:1244-1249.
102. Crum NF, Higginbottom PA, Fehl FC, et al. Sweet's syndrome masquerading as facial cellulitis. Cutis 2003, 71:469-472.
103. Sheard RM, Pandey KR, Barnes ND, et al. Kawasaki disease presenting as orbital cellulitis. J Pediatr Ophthalmol Strabismus 2000, 37:123-125.
104. Green WH, Yosipovitch G, Pichardo RO Recurrent, pruritic dermal plaques and bullae. Diagnosis: eosinophilic cellulitis (Wells syndrome). Arch Dermatol 2007, 143:791-796.
105. Faber K, Schroeder L, Thill M-P, et al. Carcinoma erysipeloides of the neck. Lancet 2002, 359:1025.
106. Gunderson CG Cellulitis: definition, etiology, and clinical features. Am J Med 2011, 124:1113-1122.
107. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011, 52:e18-e55.
108. Busch BA, Ahern MT, Topinka M, et al. Eschar with cellulitis as a clinical predictor in community-acquired MRSA skin abscess. J Emerg Med 2010, 38:563.
109. File TM, Wilcox MH, Stein GE Summary of ceftaroline fosamil clinical trial studies and clinical safety. Clin Infect Dis 2012, 55(suppl 3):S173-S180.
110. Khawcharoenporn T, Tice A Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis. Am J Med 2010, 123:942-950.
111. Pallin DJ, Binder WD, Allen MB, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis 2013, 56:1754-1762.
112. Rockson SG Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol 2008, 52:799-806.
113. Thomas KS, Crook AM, Nunn AJ, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med 2013, 368:1695-1703. U.K. Dermatology Clinical Trials Network's PATCH I Trial Team.
114. Lowe CF, Bernard KA, Romney MG Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review. J Clin Microbiol 2011, 49:2664-2666.
115. Belsey MA, Sinclair M, Roder MR, et al. Corynebacterium diphtheriae skin infections in Alabama and Louisiana: a factor in the epidemiology of diphtheria. N Engl J Med 1969, 280:135-141.
116. Gruner E, Opravil M, Altwegg M, et al. Nontoxigenic Corynebacterium diphtheriae isolated from intravenous drug users. Clin Infect Dis 1994, 18:94-96.
117. Golaz A, Hardy IR, Strebel P, et al. Epidemic diphtheria in the newly independent states of the former Soviet Union: implications for diphtheria control in the United States. J Infect Dis 2000, 181(suppl 1):S237-S243.
118. Barker FG, Leppard BJ, Seal DV Streptococcal necrotizing fasciitis: comparison between histological and clinical features. J Clin Pathol 1987, 40:335-341.
119. Aitken DR, Mackett MC, Smith LL The changing pattern of hemolytic streptococcal gangrene. Arch Surg 1982, 117:561-567.
120. Stevens DL Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995, 1:69-78.
121. Strasberg SM, Silver MS Hemolytic streptococcus gangrene: an uncommon but frequently fatal infection in the antibiotic era. Am J Surg 1968, 115:763-768.
122. Meleney FL Bacterial synergism in disease processes with a confirmation of the synergistic bacterial etiology of a certain type of progressive gangrene of the abdominal wall. Ann Surg 1931, 94:961-981.
123. Davson J, Jones DM, Turner L Diagnosis of Meleney's synergistic gangrene. Br J Surg 1988, 75:267-271.
124. Turner L, Jones DM, Davson J Cutaneous amoebiasis: case report. BMJ 1985, 291:635-636.
125. Boyd AS, Wiser B, Sams HH, et al. Gangrenous cutaneous mucormycosis in a child with a solid organ transplant: a case report and review of the literature. Pediatr Dermatol 2003, 20:411-415.
126. Antoniadou A Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect 2009, 15(suppl 5):55-59.
127. Wilson CB, Siber GR, O'Brien TF, Morgan AP Phycomycotic gangrenous cellulitis. A report of two cases and a review of the literature. Arch Surg 1976, 111:532-538.
128. Gomes MZ, Lewis RE, Kontoyiannis DP Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 2011, 24:411-445.
129. Rogers NM, Teubner DJ, Coates PT Calcific uremic arteriolopathy: advances in pathogenesis and treatment. Semin Dial 2007, 20:150-157.
130. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
131. Coyle EA, Cha R, Ryback MJ Influences of linezolid, penicillin, and clindamycin alone and in combination, on streptococcal pyrogenic exotoxin A release. Antimicrob Agents Chemother 2003, 47:1752-1755.
132. Miller SD, David-Bajar K Images in clinical medicine. a brilliant case of erythrasma. N Engl J Med 2004, 351:1666.
133. Turk BG, Turkmen M, Aytimur D Antibiotic susceptibility of Corynebacterium minutissimum isolated from lesions of Turkish patients with erythrasma. J Am Acad Dermatol 2011, 65:1230-1231.
134. Takama H, Tamada Y, Yano K, et al. Pitted keratolysis: clinical manifestations in 53 cases. Br J Dermatol 1997, 137:282-285.
135. Bowler PG, Duerden BI, Armstrong DG Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001, 8:244-269.
136. Khanolkar MP, Bain SC, Stephens JW The diabetic foot. QJM 2008, 101:685-695.
137. Gerding DM Foot infections in diabetic patients: role of anaerobes. Clin Infect Dis 1995, 20(suppl 2):S283-S288.
138. Eleftheriadou I, Tentolouris N, Argiana V, et al. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 2010, 70:1785-1797.
139. Janda JM, Abbott SL, Brenden RA Overview of the etiology of wound infections with particular emphasis on community-acquired illnesses. Eur J Clin Microbiol Infect Dis 1997, 16:189-201.
140. Haagsma JA, Tariq L, Heederik DJ, et al. Infectious disease risks associated with occupational exposure: a systematic review of the literature. Occup Environ Med 2012, 69:140-146.
141. Agger WA, Cogbill TH, Busch H, et al. Wounds caused by corn-harvesting machines: an unusual source of infection due to gram-negative bacilli. Rev Infect Dis 1986, 8:927-931.
142. Weinstein MR, Litt M, Kertess DA, et al. Invasive infections due to a fish pathogen, Streptococcus iniae. N Engl J Med 1997, 337:589-594.
143. Eiland LS, Salazar ML Polymicrobial catfish spine infection in a child. Pediatr Infect Dis J 2006, 25:281-282.
144. Bottone EJ Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev 2010, 23:382-398.
145. Centers for Disease Control and Prevention Outbreak of cutaneous Bacillus cereus infections among cadets in a university military program-Georgia, August 2004. MMWR Morb Mortal Wkly Rep 2005, 54:1233-1235.
146. Hussein MR Mucocutaneous Splendore-Hoeppli phenomenon. J Cutan Pathol 2008, 35:979-988.
147. Gavin PJ, Das L, Chadwick EG, et al. Botryomycosis in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2000, 19:900-901.
148. Marcoux D, Jafarian F, Joncas V, et al. Deep cutaneous fungal infections in immunocompromised children. J Am Acad Dermatol 2009, 61:857-864.
149. Mays SR, Bogle MA, Bodey GP Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol 2006, 7:31-43.
150. Chao SC, Hsu MM, Lee JY Cutaneous protothecosis: report of five cases. Br J Dermatol 2002, 146:688-693.
151. Nir-Paz R, Elinav H, Pierard GE, et al. Deep infection by Trichophyton rubrum in an immunocompromised patient. J Clin Microbiol 2003, 41:5298-5301.
152. Karakas M, Aksungur VL, Homan S, et al. Bacillary angiomatosis on a region of burned skin in an immunocompetent patient. Br J Dermatol 2000, 143:609-661.
153. Chian CA, Arrese JE, Piérard GE Skin manifestations of Bartonella infections. Int J Dermatol 2002, 41:461-466.
154. Murillo O, Mimbrera D, Petit A, et al. Fatal bacillary angiomatosis mimicking an infiltrative vascular tumour in the immune restoration phase of an HIV-infected patient. Antivir Ther 2012, 17:405-407.
155. Jemec GB Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012, 366:158-164.
156. Cosmatos I, Matcho A, Weinstein R, et al. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. Am Acad Dermatol 2013, 68:412-419.
157. Fismen S, Ingvarsson G, Moseng D, et al. A clinical-pathological review of hidradenitis suppurativa: using immunohistochemistry one disease becomes two. APMIS 2012, 120:433-440.
158. Dréno B, Khammari A, Brocard A, et al. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol 2012, 148:182-186.
159. Lim DT, James NM, Hassan S, et al. Spondyloarthritis associated with acne conglobata, hidradenitis suppurativa and dissecting cellulitis of the scalp: a review with illustrative cases. Curr Rheumatol Rep 2013, 15:346.
160. Yazdanyar S, Jemec GB Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis 2011, 24:118-123.
161. Blok JL, van Hattem S, Jonkman MF, et al. Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. Br J Dermatol 2013, 168:243-252.
162. Brook I The role of anaerobic bacteria in cutaneous and soft tissue abscesses and infected cysts. Anaerobe 2007, 13:171-177.
163. Nielsen K, Jeppesen M, Simmelsgaard L, et al. Self-inflicted skin diseases: a retrospective analysis of 57 patients with dermatitis artefacta seen in a dermatology department. Acta Derm Venereol 2005, 85:512-515.
164. Kingston ME, Mackey D Skin clues in the diagnosis of life-threatening infections. Rev Infect Dis 1986, 8:1-11.
165. Bourelly PE, Grossman ME Subcutaneous nodule as a manifestation of Pseudomonas sepsis in an immunocompromised host. Clin Infect Dis 1998, 26:188-189.
166. Huminer D, Siegman-Igra Y, Morduchowicz G, et al. Ecthyma gangrenosum without bacteremia: report of six cases and review of the literature. Arch Intern Med 1987, 147:299-301.
167. Reich HL, Williams Fadeyi D, Naik NS, et al. Nonpseudomonal ecthyma gangrenosum. J Am Acad Dermatol 2004, 50(suppl):S114-S117.
168. Benoit FL Chronic meningococcemia. Am J Med 1963, 35:103-112.
169. Dupin N, Lecuyer H, Carlotti A, et al. Chronic meningococcemia cutaneous lesions involve meningococcal perivascular invasion through the remodeling of endothelial barriers. Clin Infect Dis 2012, 54:1162-1165.
170. O' Brien JP, Goldenberg DL, Rice PA Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 1983, 62:395-406.
171. Rice PA Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 2005, 19:853-861.
172. Rompalo AM, Hook EW, Roberts PL, et al. The acute arthritis-dermatitis syndrome: the changing importance of Neisseria gonorrhoeae and Neisseria meningitidis. Arch Intern Med 1987, 147:281-283.
173. Chartrand SA, Harrison CJ Buccal cellulitis reevaluated. Am J Dis Child 1986, 140:891-893.
174. Drapkin MS, Wilson ME, Shrager SM, Rubin RH Bacteremic Haemophilus influenzae type B cellulitis in the adult. Am J Med 1977, 63:449-452.
175. Burman WJ, Cohn DL, Reves RR, Wilson ML Multifocal cel-lulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin Infect Dis 1995, 20:564-570.
176. Shimizu S, Inokuma D, Watanabe M, et al. Cutaneous manifestations of Helicobacter cinaedi infection. Acta Derm Venereol 2013, 93:165-167.
177. Marrie TJ Osler's nodes and Janeway lesions. Am J Med 2008, 121:105-106.
178. Cardullo AC, Silvers DN, Grossman ME Janeway lesions and Osler's nodes: a review of histopathologic findings. J Am Acad Dermatol 1990, 22:1088-1090.
179. Røder BL, Wandall DA, Frimodt-Moller N, et al. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 1999, 159:462-469.
180. Kimyai-Asadi A, Usman A, Milani F Cutaneous manifestations of marantic endocarditis. Int J Dermatol 2000, 39:290-292.
181. Li Y, Muench A, McGregor DH, et al. Cerebral, myocardial and cutaneous ischemic necrosis associated with calcific emboli from aortic and mitral valve calcification in a patient with end-stage renal disease. Clin Nephrol 2002, 57:468-473.
182. Bae GY, Lee HW, Chang SE, et al. Clinicopathologic review of 19 patients with systemic candidiasis with skin lesions. Int J Dermatol 2005, 44:550-555.
183. Jarowski CI, Fialk MA, Murray HW, et al. Fever, rash, and muscle tenderness: a distinctive clinical presentation of disseminated candidiasis. Arch Intern Med 1978, 138:544-546.
184. Farag SS, Firkin FC, Andrew JH, et al. Fatal disseminated Scedosporium inflatum infection in a neutropenic immunocompromised patient. J Infect 1992, 25:201-204.
185. Stone HH, Martin JJ Synergistic necrotizing cellulitis. Ann Surg 1972, 175:702-711.
186. George WL Other infections of skin, soft tissue, and muscle. Anaerobic Infections in Humans 1989, 492-504. Academic Press, New York. S.M. Finegold, W.L. George (Eds.).
187. Moses AE, Hardan I, Simhon A, et al. Clostridium septicum bacteremia and diffuse spreading cellulitis of the head and neck in a leukemic patient. Rev Infect Dis 1991, 15:525-527.
188. MacLennan JD The histotoxic clostridial infections of man. Bacteriol Rev 1962, 26:177-276.
189. Bryant P, Carapetis J, Matussek J, et al. Recurrent crepitant cellulitis caused by Clostridium perfringens. Pediatr Infect Dis J 2002, 21:1173-1174.
190. Bessman AN, Wagner W Nonclostridial gas gangrene. JAMA 1975, 233:958-963.
191. Lancerotto L, Tocco I, Salmaso R, et al. Necrotizing fasciitis: classification, diagnosis, and management. J Trauma Acute Care Surg 2012, 72:560-566.
192. Sarani B, Strong M, Pascual J, et al. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg 2009, 208:279-288.
193. Aronoff DM, Bloch KC Assessing the relationship between the use of nonsteroidal anti-inflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore) 2003, 82:225-235.
194. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989, 321:1-7.
195. Wilson GJ, Talkington DF, Guber W, et al. Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin Infect Dis 1995, 20:1333-1338.
196. Johansson L, Thulin P, Low DE, et al. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis 2010, 51:58-65.
197. Vlaminckx BJ, Schuren FH, Montijn RC, et al. Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray. Infect Immun 2007, 75:2603-2611.
198. Llewelyn M Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shock. Clin Infect Dis 2005, 41(suppl 7):S445-S448.
199. Casali RE, Tucker WE, Petrino RA, et al. Postoperative necrotizing fasciitis of the abdominal wall. Am J Surg 1980, 140:787-790.
200. Underwood TJ, Southgate J, Talbot R, et al. Perforated diverticulitis presenting as necrotising fasciitis of the leg. World J Emerg Surg 2008, 3:10.
201. Chen JL, Fullerton KE, Flynn NM Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 2001, 33:6-15.
202. Kimura AC, Higa JI, Levin RM, et al. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis 2004, 38:e87-e91.
203. Fraser N, Davies BW, Cusack J Neonatal omphalitis: a review of its serious complications. Acta Paediatr 2006, 95:519-522.
204. Anaya DA, Dellinger EP Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007, 44:705-710.
205. Eke N Fournier's gangrene: a review of 1726 cases. Br J Surg 2000, 87:718-728.
206. Corcoran AT, Smaldone MC, Gibbons EP, et al. Validation of the Fournier's gangrene severity index in a large contemporary series. J Urol 2008, 180:944-948.
207. Iorianni P, Oliver GC Synergistic soft tissue infections of the perineum. Dis Colon Rectum 1992, 35:640-644.
208. Bjurlin MA, O'Grady T, Kim DY, et al. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology 2013, 81:752-758.
209. Lazzeri D, Lazzeri S, Figus M, et al. Periorbital necrotising fasciitis. Br J Ophthalmol 2010, 94:1577-1585.
210. Rapoport Y, Himelfarb MZ, Zikk D, et al. Cervical necrotizing fasciitis of odontogenic origin. Oral Surg Oral Med Oral Pathol 1991, 72:15-18.
211. Weiss A, Nelson P, Movahed R, et al. Necrotizing fasciitis: review of the literature and case report. J Oral Maxillofac Surg 2011, 69:2786-2794.
212. Banerjee AR, Murty GE, Moir AA, et al. Cervical necrotizing fasciitis: a distinct clinocopathological entity?. J Laryngol Otol 1996, 110:81-86.
213. Murphy JJ, Granger R, Blair GK, et al. Necrotizing fasciitis in childhood. J Pediatr Surg 1995, 30:1131-1134.
214. Olsen RJ, Burns KM, Chen L, et al. Severe necrotizing fasciitis in a human immunodeficiency virus-positive patient caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2008, 46:1144-1147.
215. Anaya DA, McMahon K, Nathens AB, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005, 140:151-157.
216. Mills MK, Faraklas I, Davis C, et al. Outcomes from treatment of necrotizing soft-tissue infections: results from the National Surgical Quality Improvement Program database. Am J Surg 2010, 200:790-796.
217. Schmid MR, Kossman T, Duewell S Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol 1998, 170:615-620.
218. Fayad LM, Carrino JA, Fishman EK Musculoskeletal infection: role of CT in the emergency department. RadioGraphics 2007, 27:1723-1736.
219. Levenson RB, Singh AK, Novelline RA Fournier gangrene: role of imaging. RadioGraphics 2008, 28:519-528.
220. Morrison D, Blaivas M, Lyon M Emergency diagnosis of Fournier's gangrene with bedside ultrasound. Am J Emerg Med 2005, 23:544-547.
221. Stamenkovic I, Lew PD Early recognition of potentially fatal necrotizing fasciitis: use of frozen-section biopsy. N Engl Med 1984, 310:1689-1693.
222. Kaide CG, Khandelwal S Hyperbaric oxygen: applications in infectious disease. Emerg Med Clin North Am 2008, 26:571-595.
223. Abrahamian FM, Goldstein EJ Microbiology of animal bite wound infections. Clin Microbiol Rev 2011, 24:231-246.
224. Brook I Management of human and animal bite wounds: an overview. Adv Skin Wound Care 2005, 18:197-203.
225. Chin RL, Martinez R, Garmel G Gas gangrene from subcutaneous insulin administration. Am J Emerg Med 1993, 11:622-625.
226. Ebright JR, Pieper B Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am 2002, 16:697-712.
227. Biderman P, Hiatt JR Management of soft-tissue infections of the upper extremity in parenteral drug abusers. Am J Surg 1987, 154:526-528.
228. Aduan RP, Fauci AS, Dale DC, et al. Factitious fever and self-induced infection: a report of 32 cases and review of the literature. Ann Intern Med 1979, 90:230-242.
229. Reich P, Gottfried LA Factitious disorders in a teaching hospital. Ann Intern Med 1983, 99:240-247.
230. Holland SM Chronic granulomatous disease. Hematol Oncol Clin North Am 2013, 27:89-99.
231. Grimbacher B, Holland SM, Puck JM Hyper-IgE syndromes. Immunol Rev 2005, 203:244-250.
232. Shahin GS, Lerner SA Rare presentation of Streptococcus pneumoniae pneumonia with bacteremia and multiple subcutaneous abscesses. Eur J Clin Microbiol Infect Dis 2002, 21:611-612.
233. Patel VJ, Gardner E, Burton CS Vibrio vulnificus septicemia and leg ulcer. J Am Acad Dermatol 2002, 46(suppl):S144-S145.
234. Curley RK, Hayward T, Holden CA Cutaneous abscesses due to systemic nocardiosis. Clin Exp Dermatol 1990, 15:459-461.
235. Olson JM, Nguyen VQ, Yoo J, et al. Cutaneous manifestations of Corynebacterium jeikeium sepsis. Int J Dermatol 2009, 48:886-888.
236. Bisno AL, Stevens DL Streptococcal infections of skin and soft tissues. N Engl J Med 1996, 334:240-245.
237. Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5:275-286.
238. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41:1373-1406. Infectious Diseases Society of America.
239. Stanley JR, Amagai M Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006, 355:1800-1810.
240. Lappin E, Ferguson AJ Gram-positive toxic shock syndromes. Lancet Infect Dis 2009, 9:281-290.
241. Sladden MJ, Johnston GA More common skin infections in children. BMJ 2005, 330:1194-1198.
242. Johnston SL Clinical immunology review series: an approach to the patient with recurrent superficial abscesses. Clin Exp Immunol 2008, 152:397-405.
243. Demos M, McLeod MP, Nouri K Recurrent furunculosis: a review of the literature. Br J Dermatol 2012, 167:725-732.
244. Ammerlaan HS, Kluytmans JA, Wertheim HF, et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009, 48:922-930.
245. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44:178-185.
246. Fritz SA, Hogan PG, Camins BC, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013, 57:559-568.
247. Wasserzug O, Valinsky L, Klement E, et al. A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes. Clin Infect Dis 2009, 48:1213-1219.
248. Swartz MN Recognition and treatment of anthrax: an update. N Engl J Med 2001, 345:1621-1626.
249. Leclerc S, Teixeira A, Mahé E, et al. Recurrent erysipelas: 47 cases. Dermatology 2007, 214:52-57.
250. Swartz MN Cellulitis. N Engl J Med 2004, 350:904-912.
251. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012, 54:e132-e173.
252. Brooke CJ, Riley TV Erysipelothrix rhusiopathiae: bac-teriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol 1999, 48:789-799.
253. Lewin MR, Knott P, Lo M Seal finger. Lancet 2004, 364:448.
254. Gold WL, Salit IE Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis 1993, 16:69-74.
255. Dechet AM, Yu PA, Koram N, et al. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006. Clin Infect Dis 2008, 46:970-976.
256. Majeed HA, Quabazard Z, Hijasi Z, et al. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis): a six-year study. QJM 1990, 75:607-616.
257. Abbas O, Kibbi AG, Rubeiz N Sweet's syndrome: retrospective study of clinical and histologic features of 44 cases from a tertiary care center. Int J Dermatol 2010, 49:1244-1249.
258. Green WH, Yosipovitch G, Pichardo RO Recurrent, pruritic dermal plaques and bullae. Diagnosis: eosinophilic cellulitis (Wells syndrome). Arch Dermatol 2007, 143:791-796.
259. Faber K, Schroeder L, Thill M-P, et al. Carcinoma erysipeloides of the neck. Lancet 2002, 359:1025.
260. Gunderson CG Cellulitis: definition, etiology, and clinical features. Am J Med 2011, 124:1113-1122.
261. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011, 52:e18-e55.
262. Thomas KS, Crook AM, Nunn AJ, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med 2013, 368:1695-1703. U.K. Dermatology Clinical Trials Network's PATCH I Trial Team.
263. Lowe CF, Bernard KA, Romney MG Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review. J Clin Microbiol 2011, 49:2664-2666.
264. Belsey MA, Sinclair M, Roder MR, et al. Corynebacterium diphtheriae skin infections in Alabama and Louisiana: a factor in the epidemiology of diphtheria. N Engl J Med 1969, 280:135-141.
265. Stevens DL Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995, 1:69-78.
266. Davson J, Jones DM, Turner L Diagnosis of Meleney's synergistic gangrene. Br J Surg 1988, 75:267-271.
267. Miller SD, David-Bajar K Images in clinical medicine. a brilliant case of erythrasma. N Engl J Med 2004, 351:1666.
268. Bowler PG, Duerden BI, Armstrong DG Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001, 8:244-269.
269. Haagsma JA, Tariq L, Heederik DJ, et al. Infectious disease risks associated with occupational exposure: a systematic review of the literature. Occup Environ Med 2012, 69:140-146.
270. Bottone EJ Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev 2010, 23:382-398.
271. Centers for Disease Control and Prevention Outbreak of cutaneous Bacillus cereus infections among cadets in a university military program-Georgia, August 2004. MMWR Morb Mortal Wkly Rep 2005, 54:1233-1235.
272. Mays SR, Bogle MA, Bodey GP Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol 2006, 7:31-43.
273. Chian CA, Arrese JE, Piérard GE Skin manifestations of Bartonella infections. Int J Dermatol 2002, 41:461-466.
274. Jemec GB Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012, 366:158-164.
275. Blok JL, van Hattem S, Jonkman MF, et al. Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. Br J Dermatol 2013, 168:243-252.
276. Nielsen K, Jeppesen M, Simmelsgaard L, et al. Self-inflicted skin diseases: a retrospective analysis of 57 patients with dermatitis artefacta seen in a dermatology department. Acta Derm Venereol 2005, 85:512-515.
277. Kingston ME, Mackey D Skin clues in the diagnosis of life-threatening infections. Rev Infect Dis 1986, 8:1-11.
278. Dupin N, Lecuyer H, Carlotti A, et al. Chronic meningococcemia cutaneous lesions involve meningococcal perivascular invasion through the remodeling of endothelial barriers. Clin Infect Dis 2012, 54:1162-1165.
279. Marrie TJ Osler's nodes and Janeway lesions. Am J Med 2008, 121:105-106.
280. Chen JL, Fullerton KE, Flynn NM Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 2001, 33:6-15.
281. Bjurlin MA, O'Grady T, Kim DY, et al. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology 2013, 81:752-758.
282. Abrahamian FM, Goldstein EJ Microbiology of animal bite wound infections. Clin Microbiol Rev 2011, 24:231-246.
283. Holland SM Chronic granulomatous disease. Hematol Oncol Clin North Am 2013, 27:89-99.
284. Grimbacher B, Holland SM, Puck JM Hyper-IgE syndromes. Immunol Rev 2005, 203:244-250.